Versant Venture Capital V, L.p. - Net Worth and Insider Trading

Over the past 18 months, Versant Venture Capital V, L.p. made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital V, L.p. made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .

In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital V, L.p. made no insider transaction in Crinetics Pharmaceuticals Inc (CRNX). Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 40,035 shares made by Stephen F. Betz , a net sale of 134,049 shares made by Marc Wilson , and a net sale of 85,509 shares made by Dana Pizzuti .

In summary, during the past 3 months, insiders sold 174,051 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 174,051 shares. During the past 18 months, 882,807 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 877,807 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital V, L.p. made no insider transaction in Gritstone Bio Inc (GRTS). Other recent insider transactions involving Gritstone Bio Inc (GRTS) include a net sale of 1,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Erin Jones .

In summary, during the past 3 months, insiders sold 0 shares of Gritstone Bio Inc (GRTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 74,769 shares of Gritstone Bio Inc (GRTS) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 62,769 shares.

Gritstone Bio Inc (GRTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital V, L.p. made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 225,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .

In summary, during the past 3 months, insiders sold 3,366 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 3,366 shares. During the past 18 months, 238,087 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,087 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital V, L.p. made no insider transaction in Turnstone Biologics Corp (TSBX). Other recent insider transactions involving Turnstone Biologics Corp (TSBX) include a net purchase of 416,666 shares made by Rishi Gupta , a net purchase of 416,666 shares made by Orbimed Advisors Llc , and a net purchase of 225,000 shares made by Versant Ventures V, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Turnstone Biologics Corp (TSBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turnstone Biologics Corp (TSBX) were sold and 1,283,332 shares were bought by its insiders, resulting in a net purchase of 1,283,332 shares.

Turnstone Biologics Corp (TSBX)'s detailed insider trading history can be found in Insider Trading Tracker table.